Latest Breaking News On - Bsip universal images group - Page 1 : comparemela.com

Bsip/Universal Images Group via Getty Images(WASHINGTON) A new immunization to protect infants from respiratory syncytial virus, or RSV was approved by the Centers for Disease Control and Prevention on Thursday. The approved drug called nirsevimab, which will be marketed in the U.S. by Sanofi as Beyfortus, was recommended unanimously by the CDC s Advisory Committee on Immunization Practice for all children under 8 months old and signed off on by CDC director Dr. Mandy Cohen, the last step in the regulatory process. It comes less than two weeks after the Food and Drug Administration approved the shot, with both federal agencies saying it s safe and effective at protecting infants against the risk of severe infection and hospitalization from RSV. Beyfortus is a one-dose shot made of monoclonal antibodies, which are proteins manufactured in a lab and mimic the antibodies the body naturally creates when fighting an infection. Though given as an intramuscular injection, this shot is di

United statesMichael greenbergMandy cohenThomas triompheAdvisory committee on immunization practiceDrug administrationBsip universal images groupCenters for diseaseUniversal images groupDisease controlImmunization practiceAmerican indianNorth americaNew england journalHits fm hit music covering 5 decades michigan wqlb wkjz greatest of all time